Kuros Biosciences AG (SWX:KURN)

Market Cap	1.02B +16.2%
Revenue (ttm)	103.35M +129.8%
Net Income	-6.07M
EPS	-0.13
Shares Out	39.18M
PE Ratio	n/a
Forward PE	81.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	485,790
Average Volume	153,448
Open	28.10
Previous Close	28.44
Day's Range	25.62 - 28.10
52-Week Range	14.00 - 34.20
Beta	0.63
RSI	47.90
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 158
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.